The plasma membrane contains distinct domains that are characterized by a high concentration of sphingolipids and cholesterol. These membrane microdomains also referred to as rafts, seem to be intimately involved in transmembranous signaling and often initiate interactions of pathogens and the host cell membranes. Here, we investigated the further reorganization of membrane rafts in cultured epithelial cells and ex vivo isolated nasal cells after infection with rhinoviruses. We demonstrate the formation of ceramide-enriched membrane platforms and large glycosphingolipid-enriched membrane domains and the co-localization of fluorochrome-labeled rhinoviruses with these membrane domains during attachment and uptake of human rhinovirus. Destruction of glycosphingolipid-enriched membrane domains blocked infection of human cells with rhinovirus. Furthermore, our studies indicate that the activation of the acid sphingomyelinase (ASM) is intrigued in the formation of ceramide-or GM1-enriched membrane platforms. Inhibition of the ASM reduces the number of ceramide-enriched platforms and glycosphingolipid-enriched membrane domains. These data reveal a critical role of the ASM for the formation of membrane platforms and infection of human cells with rhinoviruses.
Introduction
The classical fluid mosaic model of the cell membrane suggests a random distribution of lipids and proteins in the cell membrane [1] . However, this view was challenged by many recent studies indicating that sphingolipids and cholesterol spontaneously separate from glycophospholipids in the cell membrane to form distinct microdomains [2, 3] . Sphingolipids bind to each other via hydrophilic interactions between their headgroups and the saturated fatty acid side chains, respectively. Void spaces between the bulky glycosphingolipids appear to be filled with cholesterol. The sterol ring system interacts thightly with the sphingosine moiety of the sphingolipids via hydrogen boundings between the C3 hydroxylgroup and the hydrophilic headgroup of sphingomyelin. These interactions result in a lateral stabilization and facilitate 242 the formation of distinct membrane domains termed rafts [3, 4] .
Recent studies indicate that rafts are also central for the infection of mammalian cells with pathogens including bacteria, such as Pseudomonas aeruginosa, Salmonella typhi, Shigella enterocolitica, Vibrio cholerae, Clostridium difficile, and viruses, e.g. Influenza virus, HIV-1 (human immunodeficiency virus type 1), Respiratory syncytial cell virus, SV40 (simian virus type 40) or measles virus [5-17, for review see 18] . However, the detailed role of rafts for cellular infection with pathogens requires definition.
In the present study we investigated the role of membrane rafts for the infection of mammalian respiratory epithelial cells with human rhinoviruses.
Rhinoviruses belong to the picornaviridae family and are small, positive-stranded RNA viruses. Infection is restricted to the upper airway epithelium resulting in the common cold. Rhinoviruses are classified into two subgroups, designated the minor and the major group. The attachment and entry of minor group rhinoviruses is mediated via the LDL (low density lipoprotein) receptor family [19] [20] [21] , whereas the major group rhinoviruses bind to the ICAM-1 (intercellular adhesion molecule type 1, CD54) receptor [22] . However, the details of rhinovirus invasion remain to be clarified, particularly since ICAM-1 expression has not been detected in nasal epithelial cells [23, 24] . Upon binding of the virus to its receptor, rhinoviruses are rapidly internalized into vesicles, the genomic RNA is finally released into the cytoplasm and is directly translated into a single polypeptide chain, which is cleaved into four capsid proteins and the viral polymerase. Recent data indicated that induction of specialized membrane domains, i.e. ceramide-enriched membrane platforms, play a crucial role for infection of mammalian cells with rhinovirus [25] . The formation of ceramide-enriched membrane platforms requires the activation of the acid sphingomyelinase (ASM). Fibroblasts isolated from Niemann-Pick patients lacking functional ASM exhibited a reduced viral titer after incubation with human rhinoviruses. Treatment of epithelial cells and fibroblasts with pharmacological inhibitors of the ASM revealed comparable results [25] .
Here, we show that infection results in formation of glycosphingolipid-enriched membrane domains of the GM-1 (ganglioside type 1) type. Furthermore, we demonstrate the interaction of rhinoviruses and distinguishable membrane domains by in situ studies using rhinoviruses with fluorochrome-labeled genomic RNA. Disruption of membrane rafts by methyl-β-cyclodextrin, nystatin or filipin prevented membrane domain and platform formation and cellular infection with rhinoviruses. Moreover, we observed that GM-1 positive membrane platforms correspond at least in part to ceramide-enriched membrane platforms. We addressed the question, whether GM-1 positive membrane platforms are derivatives of ceramide-enriched platforms synthesized by the ASM. Administration of ASM specific siRNA down-regulated the formation of ceramide-enriched platforms as well as of GM-1 positive membrane platforms. This suggests that the formation of GM-1 positive membrane domains is also dependent on activation of the ASM at least for some strains of rhinoviruses. Finally, we established an experimental model using primary cells from nasal epithelial tissue to examine the rearrangement of lipids upon rhinoviral infection ex vivo. The results indicate that distinct membrane domains are functional in rhinoviral infections in vivo.
Material and Methods
Cell culture, viral stocks and labeling of rhinoviruses Epithelial cells and fibroblasts were purchased from ATCC (HeLa epithelial cells ATCC stock number: CCL-2; Wi-38 fibroblasts ATCC stock number: CCL-75) and cultured in MEM medium (HeLa cells) supplemented with 10% FCS, 10 mM HEPES, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 µM non-essential amino acids, 100 units/ml penicillin, 100 µg/ml streptomycin (all purchased from GIBCO/BRL-Life Technologies, Grand Islands, N.Y., USA).
Human rhinovirus type 2 and type 14 (RV2 and RV14) were purchased by ATCC (human rhinovirus type 2 ATCC #21112, human rhinovirus type 14 ATCC #284) and propagated by infection of HeLa cells with a multiplicity of infection (MOI) of 0.01 in DMEM medium supplemented with 2% FCS and 20 mM MgCl 2 referred to as infection medium to enhance viral adsorption. Adsorption of the virus was allowed for 1 hr at 37°C followed by removal of the medium and culture in standard medium for 3-4 days at 33°C. Culture at 33°C resembles the temperature condition in the nasal epithelium and leads to more efficient replication of rhinoviruses. Samples were centrifuged for 10 min at 600xg to separate cellular debris and intact cells. Viruses in the supernatant were collected and stored at -80°C.
Rhinoviruses were purified by ultracentrifugation on a sucrose gradient [26] . Purified rhinoviruses were noncovalently labeled by incubation with a RNA binding dye (Ribogreen TM Molecular Probes, Eugene, Oregon, USA) as previously described [27] . Labeled rhinoviruses were separated from non-incorporated fluorochrome by additional centrifugation in a Centricon MW 100 filter system as recommended by the manufacturer (Millipore GmbH, Schwalbach, Germany). Viral titers were measured by performing TCID Assays in triplicate. HeLa cells were seeded in 96-well plates at a density of 5x10 confluency and infected as described above. After four days at 33°C cell layers were stained with crystal-violet (0.07% w/v in EtOH). The viral titers were determined by calculating the tissue culture infective dose (TCID 50/ml) according to the method of Blake and O'Connell [28] .
Infection and treatment of cultured cells
Rafts in cultured cells were destroyed by incubation with nystatin (final concentration 10 -30 µg/ml), filipin (final concentration 0.5 -1.5 µg/ml) or methyl-β-cyclodextrin (final concentration: 1 mM; all obtained from Sigma) that were added to the cells 30 min prior to infection. These agents interfere with cholesterol metabolism resulting in the disruption of rafts. The inactive isomer α-cyclodextrin (final concentration 1 mM) served as control. For the formation-inhibition of ceramideenriched membrane platforms and GM-1 positive membrane platforms respectively, cholera toxin-subunit B was added at a final concentration of 2.5 µg/ml and anti-ceramide antibody MAB15B4 at a final concentration of 2.5 µg/ml (both supplied by Sigma) 15 min before infection. For control studies cells were pretreated with a RV2 neutralizing antibody (rabbit antiserum, diluted 1:100 [29] , courtesy of Prof. Dr. D. Blaas, University of Vienna, Austria) or biotin-labeled transferrin as described elsewhere [30] . Cells were washed and infected with RV2 and RV14 at an MOI of 20 in infection medium. Rhinoviruses were allowed to attach to the cells at 37°C for 10 min and cells were washed in PBS (137 mM sodium chloride, 10 mM phosphate; 2.7 mM potassium chloride, pH 7.2; phosphatebuffered saline) supplemented with MgCl 2 and CaCl 2 (5 mM each). Infection was terminated after the indicated time and cells were subjected to in situ staining techniques as given below. In studies that addressed effects of infection beyond 15 min, virus-containing medium was replaced by fresh complete medium and cells were maintained in complete medium for the indicated time prior to washing and fixation in 2% PFA/PBS (Paraformaldehyde in PBS).
Recovery of rhinoviruses from nasal tissue
Ex vivo nasal mucosa (Ethic comission of the University Clinics Essen-Duisburg permission number: 06-3127) were cut into pieces of 10 mg fresh weight, rinsed twice in PBS and equilibrated in MEM complete medium for 2 hrs. Cells were infected with RV2 or RV14 for 2 hrs at 37°C with 10 8 pfu/ml in infection medium. Samples were washed vigorously after infection and subjected to four freeze-thaw cycles to release virus from the cells. The samples were centrifuged at 5000xg at 4°C for 10 min to remove debris and the supernatants were collected. The supernatants were used for reinfection of HeLa cells in a modified plaque-assay. Since the number of rhinoviruses in these supernatants reflects the number of viruses that had previously infected the nasal epithelial cells, a reinfection enables the calculation of the TCID. To this end, 5x10 4 HeLa cells were cultured in a 96-well plate up to 60-70% confluency, exposed to the supernatants obtained from the nasal tissues and death of HeLa cells served as a measurement for viral titers which was assessed after 12 and 24 hrs by TCID assay as described above.
If indicated, methyl-ß-cyclodextrin and α-cyclodextrin respectively (final concentration 5 mM), were added to the nasal tissues and were present throughout the total 4 hrs equilibration and infection period.
Immunohistochemistry
Rabbit polyclonal anti-RV2 and monoclonal anti-RV2 8F5 [29] were a courtesy of Prof. Dr. D. Blaas (University of Vienna, Austria). All other primary and secondary antibodies were purchased from Santa Cruz Biotechnologies. Biotin-labeled choleratoxin and APC-labeled Streptavidin were obtained from Sigma.
Human nasal mucosa were handled according to the protocols used for establishing primary culture cells [31, 32] . Pieces of tissues (approximately 5x5x5 mm 3 blocks) were rinsed twice with PBS supplemented with MgCl 2 and CaCl 2 (5 mM each). The samples were infected as described above with RV2 and RV14 for 2 hrs, cells were fixed in 2% PFA in PBS (pH 7.4) for 30 min at 37°C and stained with FITC-coupled cholera-toxin B-subunit (1:100 diluted) to detect ganglioside type1 (GM-1). Alternatively, GM-1 was detected by incubation with nonlabeled cholera-toxin-B subunit and usage of an anticholera-toxin-B subunit specific antibody (anti CTX-B polyclonal antiserum, 1:200 diluted, Sigma). After staining, the tissue was washed twice, dissected mechanically and analyzed by fluorescence microscopy.
Cultured epithelial cells (HeLa cells) were grown on cover slides overnight under standardized growth conditions, infected as described above, washed twice in PBS supplemented with 5 mM each MgCl 2 and CaCl 2 and fixed in 2% PFA in PBS (pH 7.4) for 10 min. Cells were washed twice in PBS and nonspecific binding sites were blocked by incubation in BSA dissolved in PBS (1% w/v) for 30 min. The anti-RV2 serum was pre-absorbed for 30 min at room temperature on non-infected HeLa cells. Subsequently, the cells were washed in PBS and incubated with pre-absorbed anti-RV2 serum (diluted 1:100) for 2 hrs at room temperature. The samples were washed again and incubated with biotin-labeled cholera-toxin subunit-B (1:100 diluted in PBS) for 20 min at room temperature. Cells were washed three times with PBS and consecutively stained with FITC-and Cy3-coupled secondary antibodies and APC-labeled streptavidin, respectively. All agent concentrations were used as recommended by the manufacturer. Cells were finally washed three times in PBS and mounted in mowiol (mixture of 2.4 g mowiol (polyvinyl ethanol, Carl Roth, Karlsuhe, Germany) and 6 g glycerin in 20 ml Tris pH 8. The silencing effect of the siRNA was controlled by ASM enzyme assays as described elsewhere [33] . 
Microscopy and FACS analysis
Fluorescence microscopy was performed using an inverse LEICA DM IRES 2 microscope. Digitalized pictures were collected and processed using the Q-FLUORO program (Leica, Germany). Laser scanning microscopy was performed on a LEICA TSP2 module linked to a LEICA DM IRES 2 Microscope. rhinovirus or siRNA transfected cells was performed on a FACScalibur (BD Becton Dickinson, Heidelberg, Germany). For FACS analysis with cells infected by ribogreen-labeled rhinovirus, cells were washed in PBS after infection, fixed in Paraformaldehyde/PBS, washed again in PBS as described before. HeLa cells which were infected with RV2 were washed with PBS after infection, trypsinized and permeabilized by incubation in PBS, 0.1% v/v Triton-X-100 for 5 min and subsequently stained with anti-RV2 antibody 8F5 as described previously [30] .
Results

Fluorochrome-labeling of the rhinoviral genome enables tracking of virus in vitro
In a first experiment we infected HeLa cells with purified, fluorochrome-labeled rhinoviruses of the strains 2 (minor group) or 14 (major group). Control experiments employing the ribogreen-containing filtrate resulting from the purification procedure excluded a significant background staining with this novel procedure. Infected HeLa cells exhibited an intense staining, characterized by single or clustered particles representing most likely viral capsids (Fig. 1A) . To clarify this finding, we incubated HeLa cells infected by ribogreen-labeled RV2 with the anti-RV2 antibody 8F5, which predominatly detects internalized rhinoviruses. The ribogreen positive particles were co-stained by the anti-RV2 antibody, confirming the specificity of the labelling procedure and the integrity and viability of the virus (Fig. 1B) . We observed clusters of ribogreen-labeled, 8F5-negative capsids at the cell membrane, representing attached but yet not incorporated rhinoviruses (Fig. 1B) .
Next, we assessed the binding and uptake of 
Rhinovirus strains 2 and 14 co-localize to ceramide-and GM1-enriched membrane platforms
Next, we wanted to determine the topology of rhinoviral infections, i.e. if rhinoviruses bind to distinct sites of the plasma membrane. HeLa epithelial cells were infected with ribogreen-labeled RV14 and RV2, respectively, for 5 min to 45 min and stained with monoclonal anti-ceramide antibodies without permeabilization. In the non-infected cells ceramide was equally distributed in the outer leaflet of the plasma membrane. Upon infection with rhinovirus, the amount of ceramide increased and ceramide aggregated in platforms (Fig. 2) . Confocal imaging showed a colocalization of RV14 and RV2 with ceramide-enriched membrane platforms within the early phase of the infection, i.e. within 5 -15 minutes after infection (Fig. 2) . Almost 80% of infected cells exhibited a co-localization of viral particles with ceramide-enriched platforms localizing in median and apical sections, whereas only few viral particles co-localized to ceramide-enriched platforms in basolateral sections. In samples infected for 45 min the number of cells exhibiting a localization of rhinoviruses within ceramide-enriched membrane platforms decreased to 45% and more rhinoviruses localized to regions without ceramide-enriched membrane platforms (Fig. 2) . To further analyze the potential of human rhinoviruses to induce or recruit membrane domains distinct from ceramide-enriched platforms, we tested non-infected and rhinoviral infected HeLa cells for their CTX-B (choleratoxin-B) binding. CTX-B binds to GM-1 (ganglioside type 1), a sphingolipid present in many membrane domains. Indeed, the infection with rhinoviruses induced GM-1 positive membrane platforms resembling the induction of ceramide-enriched platforms regarding the temporal course and intensity (Fig. 3A ) [25] . Pretreatment of HeLa cells with cholesterol depleting drugs reduced the formation of GM-1 positive membrane platforms significantly 15 minutes after infection (Fig. 3A) . In situ, GM-1 positive membrane platforms also exhibit the capacity to interact with rhinoviruses ( Fig. 3B ) from 5 to 30 minutes after infection. Therefore, we performed a double immunostaining using anti-ceramide antibodies, anti-cholera-toxin-B antibodies and compared the spatial distribution of GM-1 lipids and ceramide before and after infection with ribogreen-labeled rhinoviruses (Fig. 3C) . The anti-ceramide and the cholera-toxin-B staining resulted in a homogenous fluorescence in non-infected HeLa cells. In infected cells, ribogreen-positive viral capsids clustered in membrane regions positive for both ceramide and GM-1 (Fig. 3C) , suggesting a dynamic remodeling of membrane domains encountered by human rhinoviruses. The results indicated that both rhinoviral strains co-localize to cholera-toxin-B positive, GM-1 positive membrane platforms (Fig. 3B) .
GM-1 positive membrane platforms also associate with intracellular viruses
Next, we investigated the role of sphingolipidenriched membrane platforms in the intracellular traffic of rhinoviruses. To this end, we stained permeabilized and infected HeLa cells for GM-1, ceramide and rhinovirus. While we detected rhinoviruses associated with intracellular GM-1-enriched vesicular structures within HeLa cells (Fig. 4A) , we were unable to detect rhinovirus associated with intracellular ceramide-enriched platforms (Fig. 4B) . GM-1 positive vesicles co-localizing with rhinoviruses were predominantly grouped beyond the plasma membrane (Fig. 4A, left panel) 5 min after infection, while at 15 min after infection, RV2 loaded, GM-1 positive vesicular structures localized to perinuclear regions (Fig. 4A, central panel) . Finally, 45min after infection GM-1 enriched vesicles were shuttled back to the plasma-membrane, while RV2 positive vesicles remained in the perinuclear region of the cells (Fig. 4A,  right panel) . Comparable results were obtained for RV14 (data not shown). The latter results suggest that rhinoviruses are transported from the plasma membrane to an intracellular compartment in vesicles enriched with GM-1.
Destabilization and neutralization of membrane domains interferes with the uptake and reproduction of rhinoviruses
Recent studies suggested interactions of rhinoviruses and ceramide-enriched platforms [25, 34] . This prompted the question whether drugs that destabilize or neutralize membrane domains affect the attachment and/or uptake of rhinoviruses. The results reveal that pretreatment with cholesterol depleting drugs reduced the attachment and/ or uptake of ribogreen-labeled RV2 and RV14 at least 10-fold. The inactive stereoisomer α-cyclodextrin was without effect (Figs. 5A and B) . To further confirm the role of ceramide-enriched membrane platforms for rhinoviral attachment and/or uptake we applied anticeramide antibodies in order to compete with the interaction of rhinoviruses with these platforms. Additionaly, we selected the compound CTX-B, which binds the biochemically related sphingolipid GM-1 to clarify the role of other sphingolipids in respect to its rhinoviral binding capacity. The results demonstrate that addition of anti-ceramide antibodies and CTX-B, repectively, significantly inhibited rhinoviral attachment and/or uptake (Figs. 5A and B) . To rule out that CTX-B blocks any internalization process non-specifically, we tested the transferrin uptake in cells treated with CTX-B Fig. 7 . Induction of the acid sphingomyelinase causes the formation of GM-1 positive membrane platforms in RV2 infected cells. (A) HeLa epithelial cells were subjected to siRNA transfection, silencing the acid sphingomyelinase (ASM). Two days after transfection the ASM activity of cells was assessed by an enzymatic assay. The ASM activity prior and after infection with RV2 and RV14 was compared in siRNA transfected and non-transfected cells. Activity of the ASM was displayed by the enzymatic degradation of radiaoactive sphingomyelin [33] . under the same conditions. We found that CTX-B did not interfere with the transferrin uptake (data not shown).
In a similar experiment we treated HeLa cells with cholesterol-depleting drugs and CTX-B, respectively, prior to infection with RV2. Again, the disruption or neutralization of rafts substantially reduced the number of cells showing internalized RV2, detected by the anti-RV2 antibody 8F5 (Fig. 5C) . Next, we addressed the question whether inactivation of membrane platforms also interferes with the synthesis and release of rhinoviruses. The results reveal that methyl-ß-cyclodextrin, nystatin, filipin, CTX-B and neutralizing anti-RV2 antibody that were added 30 min prior to infection reduced viral titers by up to 100-fold in a TCID assay (Fig. 5D) . In contrast, the administration of the same CTX-B concentration postinfection did not decrease the viral titer (data not shown), suggesting that the induction of GM-1 positive membrane platforms is a prerequisite for the internalization and propagation of rhinoviruses.
Induction of GM-1 positive membrane platforms in vivo
These studies demonstrated a role of sphingolipidenriched membrane domains for the uptake as well as reproduction of human rhinoviruses. To transfer the results of our in situ studies to an ex-vivo model, we infected Rafts and Viruses Cell Physiol Biochem 2007; 20:241-254 small nasal polyps with intact epithelium cell layers with rhinoviruses. The depletion of cholesterol by methyl-β-cyclodextrin abolished the formation of GM-1 positive membrane platforms and impaired the infection with rhinovirus in vivo, while the inactive isomer α-cyclodextrin was without effect (Figs. 6A-B) . Furthermore, in situ experiments demonstrate an increase of CTX-B at the apical surface of nasal epithelial cells 30 minutes after infection, while the surface levels of GM-1 did not change in non-infected cells. As shown for cultured cells, methyl-β-cyclodextrin diminished the induction of GM-1 positive membrane platforms in the apical surface of nasal epithelial cells (Fig. 6C) . Ribogreen-labeled RV2 and RV14 were found predominantly at the apical, ciliated portion of cells (Fig.  6D ). These ex vivo data underline the importance of GM-1 positive membrane platforms for the infection of nasal epithelial cells with human rhinovirus.
Formation of ceramide-enriched platforms and GM-1 positive membrane platforms -the role of the acid sphingomyelinase (ASM)
To address the question whether GM-1 positive membrane platforms are formed from ceramide-enriched membranes or wether GM-1 positive membrane platforms are independently generated, we suppressed expression of ASM by siRNA transfection (Fig. 7A) . Control experiments confirmed that siRNA down regulated the activity of the ASM in infected and noninfected cells by 75 -80%, while non-specific siRNA was without effect. Suppression of ASM prevented the induction of ceramide-enriched membrane platforms after infection with RV2 and RV14 (Fig. 7B) . Suppression of ASM also inhibited the formation of GM-1-positive membrane platforms after transfection of HeLa cells with RV2 (Fig. 7B, C) , while there was no change in the formation of GM-1 positive membrane platforms after infection with RV14 (Fig. 7C) . This indicates that RV14 induces GM-1 positive membrane platforms in an ASMindependent manner, whereas RV2 infections recruit GM-1 positive membrane platforms via activation of the ASM.
Discussion
The present manuscript addressed the question if distinct membrane platforms serve as viral binding sites and are functional in the uptake and intracellular transport of rhinoviruses. We used a novel efficient labeling technique, which is advantageous because "ribogreen" enters capsids by diffusion and binds RNA non-covalently [27] . This avoids covalent linkages of dyes to capsid proteins that may interfere with the binding to receptor molecules. We controlled the quality of this labeling technique by double staining using the anti-RV2 antibody 8F5, which proved the specificity and efficiancy of labelling. In our study, the attachment of ribogreen-labeled rhinoviruses to cells was shown to be responsive to drugs, which destabilize rafts either by depleting cholesterol (methyl-β-cyclodextrin) or by sequestering intracellular cholesterol (nystatin, filipin). Previous studies provided evidence for the generation of ceramide-enriched membrane platforms by the activation of the ASM and their requirement for rhinoviral infection [25] . To further clarify, whether rhinoviruses attach to ceramide-enriched platforms, we administered anti-ceramide antibodies, which were able to compete with rhinoviruses for binding. Furthermore, our extended in situ studies visualized ribogreen-labeled rhinoviruses interacting with ceramideenriched membrane platforms. Our results are in line with recent studies suggesting that interactions between rafts or ceramide-enriched membrane platforms respectively, and rhinoviruses are essential for signal transduction cascades employing phosphatidyl-inositol kinase [26, 34, 35] , small GTPases and the MAP kinase P38-K [36] . A novel finding of this manuscript is the identification of GM-1 as an additional compound present in membrane domains interacting with rhinoviruses. The appearance of GM-1 in membrane domains seems to be essential not only for the attachment of rhinoviruses, but possibly for internalization of rhinoviruses by a novel yet to be characterized pathway. In situ we tracked ribogreen-and 8F5-labeled rhinoviruses and tested if intracellular compounds are positive for ceramide and/or GM-1. We found internalized rhinoviruses only co-localized to intracellular GM-1 enriched membrane domains, which are integrative compounds of transport vesicles. It might be possible that GM-1 positive vesicles are shuttling rhinoviruses to the endosomal compartment, which is necessary for the uncoating process [37, 38] . The results of the TCID assay underline that GM-1 enriched membrane platforms play a critical role in rhinoviral propagation. A recent study showed that RV2 engages the clathrin dependent internalization pathway, which is also sensitive to cholesterol depletion [30] . The same study excluded any direct interaction of RV2 and caveolae and suggests that RV2 viruses do not employ caveolae for entry. The utilization of novel, non-clathrin, non-caveolin dependent endocytosis pathways was recently demonstrated for SV40 [16] , Influenza virus [39] and 6 Garner MJ, Hayward RD, Koronakis V: The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking. Cell Microbiol 2002;4:153-165.
Coxsackieviruses [40] . Most studies concentrate their experiments on cultured cells and the results do not necessarily resemble the in vivo situation. In this regard, the role of ICAM-1 (intercellular adhesion molecule type 1) and (V)LDLR ((very) low density lipoprotein), identified as rhinoviral receptors in cultured cells, respectively, needs further clarification. Many publications found ICAM-1 only poorly distributed on the apical surface of epithelial tissues and (V)LDL receptors are present at the basolateral and lateral surface of cells. Some publications report the upregulation of both receptor types after rhinoviral infections [24, 41] , suggesting that rhinoviruses infect nasal epithelial tissues primary via another pathway possibly engaging other receptor molecules than (V)LDL receptors and ICAM-1. For cultured cells, we demonstrate the direct interaction of viral particles and ceramide/GM1 enriched membrane platforms, which are functional in the attachment and/or internalization of rhinoviruses. GM-1 positive membrane platforms are also induced in isolated nasal epithelial cells so that our experiments suggest that GM-1 positive membrane platforms play a role in attachment and/or entry in-vivo.
We were also interested in the origin of GM-1 in those membrane domains to which rhinoviruses attach. As pointed out before, infection activates the ASM and causes the formation of ceramide-enriched platforms [25] . We showed here an interaction of rhinoviruses to membrane domains containing both, ceramide and GM-1, respectively. The question arise, whether GM-1 positive membrane platforms are formed independently from ceramide-enriched platforms and both entities fuse to one functional domain or whether ceramide-enriched platforms are restructured upon contact to rhinoviruses. Ceramide can be processed enzymatically to gangliosides of the GM-1 type [42] . If so, inhibition of the ASM should suppress the formation of both, ceramide-enriched platforms and GM-1 positive membrane platforms. Supression of ASM in epithelial cells by siRNA treatment indeed substantially reduced the formation of ceramideenriched platforms upon infection. In contrast, the number of cells exhibiting GM-1 positive membrane platforms after treatment with siRNA decreased in RV2 infected cells only, whereas RV14 infected cells showed no response to the reduced concentration of ASM regarding the number of GM-1 positive membrane platforms. Thus, our results suggest a different origin of GM-1 enriched membrane domains in RV2 and RV14 infected cells.
Further studies will address the question if RV2 and RV14 activate different signal pathways leading either to the recruitment of GM-1 to ceramide-enriched membrane platforms or the generation of GM-1 on site of ceramideenriched platforms. This dynamic process could be the committing step of a rhinoviral uptake pathway, which is further characterized by the interaction of rhinoviral particles with intracellular GM-1 positive membrane platforms.
